Loading…

Aberrant Isotype Class Switch Recombination Reactivation Leads to a Genome Wide Genomic Instability in Follicular Lymphoma

Introduction Follicular lymphoma (FL) patients usually follow an indolent clinical course but suffer recurrent relapses, after few months or after long periods of remission. Many ultimately develop resistances to therapies and a subset, with an annual incidence of 2-3%, experience transformation to...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2024-11, Vol.144, p.2964-2964
Main Authors: Viennot, Mathieu, Chanussot-Godey, Marion, Rainville, Vinciane, Le Noir, Sandrine, Caillot, Melody, Drieux, Fanny, Veresezan, Elena-Liana, Vion, Roman, Viailly, Pierre-Julien, Camus, Vincent, Tilly, Hervé, Pinaud, Eric, Jardin, Fabrice, Ruminy, Philippe
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Follicular lymphoma (FL) patients usually follow an indolent clinical course but suffer recurrent relapses, after few months or after long periods of remission. Many ultimately develop resistances to therapies and a subset, with an annual incidence of 2-3%, experience transformation to DLBCL. Understanding the molecular mechanisms responsible for the clonal evolution of these tumors thus appears essential to anticipate these events. As such, two B-cells specific genetic instability processes are suspected to drive lymphomagenesis: the aberrant somatic hypermutation (ASHM) and the isotype class switch recombination (CSR). ASHM occurs when AID loses its specificity and targets multiple oncogenes while CSR, also initiated by AID, initiates double strand breaks responsible for the acquisition of chromosomal translocations. However, while it is largely recognized that ASHM usually remains active in FL cells, little is known about a possible ongoing CSR activity in these tumors and its potential impact on progression. Methods We performed a detailed analysis of the structure of the IGH loci in 16 patients: 8 with FL at diagnosis, 4 with paired FL + DLBCL (tFL) biopsies and in 5 with de novo t(14;18) positive DLBCL using high throughput IGH RNA-sequencing. Sequencing libraries were prepared using a Template Switching 5′ RACE Protocol kit (New England Biolabs) starting from total RNA extracted from fresh-frozen biopsies. Single‐end 300 bp read sequencing was performed on a MiSeq or NextSeq 550Dx system. Results In agreement with previous studies, almost all FL showed genomic hallmarks of CSR activation at diagnosis (11/12). If 6 still expressed an IgM, the IGHCµ gene was deleted from the translocated allele in 9/9 t(14;18) positive cases while 2 negative biopsies had a t(3;14) and a t(8;14) involving IGH switch regions respectively. In one FL/DLBCL pair and one de novo DLBCL, we also discovered an as yet undocumented cryptic inversion on the der(18)t(14;18). This recurrent rearrangement, which is also present in the RL cell line, joins a DNA repeated region located upstream from BCL2 with an IGH switch region, resulting in a flip of the whole intervening BCL2-IGH fusion. The localization of these breakpoints and the detection of multiple mutations around the junctions, which remind the mutations introduced by AID at physiological CSR junctions, further argue for an aberrant CSR activation during lymphomagenesis. Unexpectedly, we also observed that the
ISSN:0006-4971
DOI:10.1182/blood-2024-203479